MYCBP2 and oral cavity squamous cell carcinoma: Gene knockout assays have shown that RGS12 can inhibit the progression of oral squamous cell carcinoma by controlling the polarization of M1 in TAMs by controlling ciliated MYCBP2/KIF2A signaling64.